Neonatal death (baby born alive at any gestation and dies within 28 days) · women in labor with management of intra‐amniotic infection
It is very uncertain whether antibiotics changes neonatal deaths compared with antibiotics (very low certainty).
1 finding from 1 review
Neonatal sepsis · women in labor with management of intra‐amniotic infection
Antibiotics showed no clear difference in neonatal sepsis compared with antibiotics (low certainty).
1 finding from 1 review
Respiratory distress syndrome · women in labor with management of intra‐amniotic infection
Antibiotics showed no clear difference in respiratory distress syndrome compared with antibiotics (low certainty).
1 finding from 1 review
Maternal postpartum hospital stay (days) · women in labor with management of intra‐amniotic infection
1 finding from 1 review
Postpartum readmission for endometritis · women in labor with management of intra‐amniotic infection
1 finding from 1 review
Endometritis/Failure treatment · women in labor with management of intra‐amniotic infection
Antibiotics showed no clear difference in treatment failure (endometritis) compared with antibiotics (low certainty).
1 finding from 1 review
Need for additional IV or oral antibiotics · adults and children with cystic fibrosis (during acute exacerbations of lung disease)
It is very uncertain whether summary of findings: Inhaled antibiotics changes need for additional IV or oral antibiotics compared with IV antibiotics (very low certainty).
1 finding from 1 review
Pain ‐ pain at 24 hours · children with acute otitis media
Antibiotics showed no clear difference in pain ‐ pain at 24 hours compared with placebo (high certainty).
1 finding from 1 review
Pain ‐ pain at 2 to 3 days · children with acute otitis media
Antibiotics leads to lower pain ‐ pain at 2 to 3 days compared with placebo (high certainty).
1 finding from 1 review
Pain ‐ pain at 4 to 7 days · children with acute otitis media
Antibiotics showed no clear difference in pain ‐ pain at 4 to 7 days compared with placebo (high certainty).
1 finding from 1 review
Pain ‐ pain at 10 to 12 days · children with acute otitis media
Antibiotics probably leads to lower pain ‐ pain at 10 to 12 days compared with placebo (moderate certainty).
1 finding from 1 review
Vomiting, diarrhoea or rash · children with acute otitis media
Antibiotics leads to higher vomiting, diarrhoea or rash compared with placebo (high certainty).
1 finding from 1 review
Abnormal tympanometry ‐ 2 to 4 weeks · children with acute otitis media
Antibiotics leads to lower abnormal tympanometry ‐ 2 to 4 weeks compared with placebo (high certainty).
1 finding from 1 review
Abnormal tympanometry ‐ 3 months · children with acute otitis media
Antibiotics showed no clear difference in abnormal tympanometry ‐ 3 months compared with placebo (high certainty).
1 finding from 1 review
Clinical efficacy (RR > 1 is favored) · Participants with acute bacterial conjunctivitis
1 finding from 1 review
no estimate extracted
4 participants
Moderate
Microbiological efficacy (RR > 1 favored) · Participants with acute bacterial conjunctivitis
1 finding from 1 review
no estimate extracted
8 participants
Moderate
Treatment incompletion (RR < 1 favored) · Participants with acute bacterial conjunctivitis
Antibiotics probably leads to lower treatment incompletion (RR < 1 favored) compared with placebo (moderate certainty).
1 finding from 1 review
Persistent clinical infection after one course of treatment (RR < 1 favored) · Participants with acute bacterial conjunctivitis
Antibiotics probably leads to lower persistent clinical infection after one course of treatment (RR < 1… compared with placebo (moderate certainty).
1 finding from 1 review
Cost‐effectiveness of treatment · Participants with acute bacterial conjunctivitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment‐associated ocular complications (RR < 1 or RD ≤ 0 favored) · Participants with acute bacterial conjunctivitis
It is very uncertain whether antibiotics changes treatment‐associated ocular complications (RR < 1 or RD ≤ 0 favored) compared with placebo (very low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Very low